交易 Outset Medical, Inc. - OM CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.07 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Outset Medical Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 22.28 | 0.48 | 2.20% | 21.80 | 22.42 | 21.49 |
Jun 1, 2023 | 21.80 | 1.07 | 5.16% | 20.73 | 22.05 | 20.46 |
May 31, 2023 | 20.83 | -0.22 | -1.05% | 21.05 | 21.21 | 20.24 |
May 30, 2023 | 21.22 | -0.08 | -0.38% | 21.30 | 21.67 | 20.71 |
May 26, 2023 | 21.38 | 1.76 | 8.97% | 19.62 | 21.41 | 19.48 |
May 25, 2023 | 20.20 | 0.23 | 1.15% | 19.97 | 20.26 | 19.47 |
May 24, 2023 | 20.30 | 0.77 | 3.94% | 19.53 | 20.49 | 19.47 |
May 23, 2023 | 20.13 | -1.50 | -6.93% | 21.63 | 22.29 | 19.73 |
May 22, 2023 | 22.06 | 1.31 | 6.31% | 20.75 | 22.32 | 20.74 |
May 19, 2023 | 21.18 | 0.19 | 0.91% | 20.99 | 21.76 | 20.99 |
May 18, 2023 | 21.03 | 1.50 | 7.68% | 19.53 | 21.14 | 19.47 |
May 17, 2023 | 20.08 | 0.10 | 0.50% | 19.98 | 20.22 | 19.51 |
May 16, 2023 | 20.14 | 0.37 | 1.87% | 19.77 | 20.17 | 19.48 |
May 15, 2023 | 20.11 | 0.09 | 0.45% | 20.02 | 20.32 | 19.61 |
May 12, 2023 | 19.98 | 0.01 | 0.05% | 19.97 | 20.28 | 19.62 |
May 11, 2023 | 20.15 | -0.54 | -2.61% | 20.69 | 20.94 | 19.80 |
May 10, 2023 | 20.87 | 0.59 | 2.91% | 20.28 | 20.99 | 20.21 |
May 9, 2023 | 20.26 | 0.50 | 2.53% | 19.76 | 20.49 | 19.19 |
May 8, 2023 | 19.93 | -0.09 | -0.45% | 20.02 | 20.24 | 18.24 |
May 5, 2023 | 20.79 | -0.18 | -0.86% | 20.97 | 22.48 | 20.79 |
Outset Medical, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Monday, July 31, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q2 2023 Outset Medical Inc Earnings Release Q2 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q3 2023 Outset Medical Inc Earnings Release Q3 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
收入 | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
收入成本,共计 | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
毛利 | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
总营业费用 | 277.761 | 233.121 | 168.969 | 85.385 | 48.57 |
销售/一般/行政费用,总计 | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
研究与开发 | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
营业收入 | -162.386 | -130.519 | -119.034 | -70.307 | -46.563 |
利息收入(费用),非经营净值 | -0.275 | -1.217 | -2.365 | -1.772 | -2.93 |
其他,净值 | 0 | 0 | -0.093 | 3.8 | -0.262 |
税前净收入 | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
税后净收入 | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
未计算非常项目前的净收益 | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
净收入 | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Total Adjustments to Net Income | 0 | 42.168 | -17.163 | -23.3 | |
普通股股东可获收益 (不含非经常性项目) | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
普通股股东可获收益 (含非經常性項目) | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
摊薄净收入 | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
摊薄后加权平均股 | 48.161 | 45.589 | 42.722 | 45.2225 | 45.2225 |
扣除特别项目的每股摊薄盈利 | -3.38357 | -2.89401 | -1.85675 | -1.88981 | -1.61601 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常摊薄盈利 | -3.36512 | -2.89401 | -1.82007 | -1.88981 | -1.61601 |
异常费用(收入) | 1.367 | 0 | 1.567 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
收入 | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
收入成本,共计 | 27.039 | 26.734 | 23.425 | 21.275 | 26.108 |
毛利 | 6.428 | 5.273 | 4.336 | 3.782 | 4.442 |
总营业费用 | 76.952 | 73.198 | 68.76 | 68.778 | 67.025 |
销售/一般/行政费用,总计 | 36.12 | 33.653 | 32.276 | 33.982 | 30.086 |
研究与开发 | 13.793 | 11.444 | 13.059 | 13.521 | 10.831 |
营业收入 | -43.485 | -41.191 | -40.999 | -43.721 | -36.475 |
利息收入(费用),非经营净值 | -0.294 | -0.189 | 0.238 | -0.022 | -0.302 |
其他,净值 | 0 | ||||
税前净收入 | -43.779 | -41.38 | -40.761 | -43.743 | -36.777 |
税后净收入 | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
未计算非常项目前的净收益 | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
净收入 | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Total Adjustments to Net Income | |||||
普通股股东可获收益 (不含非经常性项目) | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
普通股股东可获收益 (含非經常性項目) | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
摊薄净收入 | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
摊薄后加权平均股 | 48.783 | 49.139 | 48.129 | 47.882 | 47.487 |
扣除特别项目的每股摊薄盈利 | -0.90136 | -0.8434 | -0.84733 | -0.91556 | -0.77689 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.90136 | -0.82532 | -0.84733 | -0.91556 | -0.77689 |
异常费用(收入) | 1.367 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 373.645 | 409.802 | 345.911 | 79.646 | 147.646 |
现金和短期投资 | 287.502 | 339.488 | 314.87 | 69.378 | 142.782 |
现金等价物 | 73.222 | 182.348 | 294.972 | 36.226 | 33.264 |
短期投资 | 214.28 | 157.14 | 19.898 | 33.152 | 109.518 |
应收账款总额,净额 | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Accounts Receivable - Trade, Net | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Total Inventory | 51.476 | 39.185 | 18.384 | 4.596 | 3.022 |
Prepaid Expenses | 6.597 | 5.529 | 6.189 | 1.058 | 0.754 |
Total Assets | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Property/Plant/Equipment, Total - Net | 21.993 | 20.195 | 23.251 | 7.895 | 2.926 |
Property/Plant/Equipment, Total - Gross | 32.8 | 27.849 | 28.239 | 10.565 | 5.149 |
Accumulated Depreciation, Total | -10.807 | -7.654 | -4.988 | -2.67 | -2.223 |
Other Long Term Assets, Total | 4.477 | 33.467 | 34.667 | 0.825 | 0.558 |
Total Current Liabilities | 51.949 | 51.695 | 36.692 | 24.91 | 10.213 |
Accounts Payable | 0.603 | 1.763 | 4.948 | 4.96 | 3.373 |
Accrued Expenses | 35.575 | 39.575 | 26.578 | 10.43 | 5.349 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 7.509 | 0.01 | ||
Other Current Liabilities, Total | 15.771 | 10.357 | 5.166 | 2.011 | 1.481 |
Total Liabilities | 154.125 | 89.383 | 75.22 | 51.107 | 46.796 |
Total Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.355 |
Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.346 |
Capital Lease Obligations | 0 | 0.009 | |||
Other Liabilities, Total | 5.84 | 7.926 | 8.854 | 4.636 | 8.228 |
Total Equity | 245.99 | 374.081 | 328.609 | 37.259 | 104.334 |
Redeemable Preferred Stock | 0 | 0 | 0 | 409.446 | 392.284 |
Common Stock | 0.048 | 0.047 | 0.043 | 0.007 | 0.006 |
Additional Paid-In Capital | 1035.46 | 1000.21 | 822.624 | 0.356 | 0 |
Retained Earnings (Accumulated Deficit) | -788.95 | -625.994 | -494.059 | -372.572 | -287.896 |
Unrealized Gain (Loss) | -0.564 | -0.184 | 0.001 | 0.022 | -0.06 |
Total Liabilities & Shareholders’ Equity | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Total Common Shares Outstanding | 48.465 | 47.241 | 42.722 | 45.2225 | 45.2225 |
Other Current Assets, Total | 0.7 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 337.275 | 373.645 | 310.003 | 345.777 | 377.426 |
现金和短期投资 | 249.213 | 287.502 | 227.517 | 262.062 | 302.267 |
现金等价物 | 36.386 | 73.222 | 63.877 | 75.497 | 114.346 |
短期投资 | 212.827 | 214.28 | 163.64 | 186.565 | 187.921 |
应收账款总额,净额 | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Accounts Receivable - Trade, Net | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Total Inventory | 47.733 | 51.476 | 55.26 | 53.689 | 42.873 |
Prepaid Expenses | 6.015 | 6.597 | 4.714 | 5.399 | 5.387 |
Total Assets | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Property/Plant/Equipment, Total - Net | 21.012 | 21.993 | 22.022 | 21.932 | 20.844 |
Other Long Term Assets, Total | 4.378 | 4.477 | 33.697 | 33.527 | 33.472 |
Total Current Liabilities | 44.268 | 51.949 | 49.644 | 55.24 | 48.89 |
Accounts Payable | 1.988 | 0.603 | 1.444 | 2.753 | 5.149 |
Accrued Expenses | 27.957 | 35.575 | 34.041 | 36.973 | 30.789 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 14.323 | 15.771 | 14.159 | 14.514 | 12.952 |
Total Liabilities | 146.379 | 154.125 | 86.619 | 91.472 | 86.289 |
Total Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Other Liabilities, Total | 5.631 | 5.84 | 7.147 | 7.426 | 7.615 |
Total Equity | 216.286 | 245.99 | 279.103 | 309.764 | 345.453 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.049 | 0.048 | 0.048 | 0.048 | 0.048 |
Additional Paid-In Capital | 1049.27 | 1035.46 | 1027.49 | 1017.4 | 1008.94 |
Retained Earnings (Accumulated Deficit) | -832.921 | -788.95 | -747.506 | -706.725 | -662.886 |
Unrealized Gain (Loss) | -0.113 | -0.564 | -0.934 | -0.955 | -0.649 |
Total Liabilities & Shareholders’ Equity | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Total Common Shares Outstanding | 49.216 | 48.465 | 48.295 | 47.997 | 47.712 |
Current Port. of LT Debt/Capital Leases | 1 | ||||
Property/Plant/Equipment, Total - Gross | 32.8 | ||||
Accumulated Depreciation, Total | -10.807 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
经营活动产生的现金 | -145.729 | -130.264 | -99.015 | -70.292 | -46.442 |
经营活动产生的现金 | 5.169 | 5.162 | 3.159 | 1.484 | 1.069 |
非现金物品 | 33.2 | 22.112 | 25.167 | -1.878 | 2.486 |
Cash Taxes Paid | 0.385 | 0.083 | 0.019 | 0.035 | 0.009 |
营运资金的变化 | -21.142 | -25.603 | -5.849 | -1.599 | -0.217 |
投资活动产生的现金 | -66.295 | -142.507 | 3.947 | 74.297 | -68.776 |
资本支出 | -8.325 | -3.108 | -9.108 | -3.293 | -1.766 |
其他投资现金流量项目,总计 | -57.97 | -139.399 | 13.055 | 77.59 | -67.01 |
融资活动产生的现金 | 72.898 | 160.147 | 385.682 | 0.249 | 134.872 |
融资现金流项目 | -0.181 | 0 | |||
股票的发行(报废),净额 | 8.042 | 160.147 | 387.046 | 0.439 | 134.881 |
债务的发行(退还),净额 | 64.856 | 0 | -1.364 | -0.009 | -0.009 |
现金净变化 | -139.126 | -112.624 | 290.614 | 4.254 | 19.654 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -43.971 | -162.956 | -121.512 | -80.731 | -36.892 |
Cash From Operating Activities | -44.756 | -145.729 | -111.222 | -76.91 | -38.335 |
Cash From Operating Activities | 1.384 | 5.169 | 3.9 | 2.586 | 1.262 |
Non-Cash Items | 8.598 | 33.2 | 23.826 | 15.118 | 6.581 |
Cash Taxes Paid | 0.201 | 0.385 | 0.334 | 0.283 | 0.205 |
Changes in Working Capital | -10.767 | -21.142 | -17.436 | -13.883 | -9.286 |
Cash From Investing Activities | 2.643 | -66.295 | -14.547 | -34.706 | -33.39 |
Capital Expenditures | -0.81 | -8.325 | -6.216 | -3.475 | -1.478 |
Other Investing Cash Flow Items, Total | 3.453 | -57.97 | -8.331 | -31.231 | -31.912 |
Cash From Financing Activities | 5.277 | 72.898 | 7.298 | 4.765 | 3.723 |
Issuance (Retirement) of Stock, Net | 5.277 | 8.042 | 7.433 | 4.765 | 3.723 |
Issuance (Retirement) of Debt, Net | 64.856 | ||||
Net Change in Cash | -36.836 | -139.126 | -118.471 | -106.851 | -68.002 |
Financing Cash Flow Items | -0.135 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 14.77 | 7270972 | 49376 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4572 | 4655616 | 82430 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.6916 | 3294148 | -225722 | 2023-03-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2155 | 3059782 | -77314 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 5.9047 | 2906759 | 63080 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 5.5577 | 2735954 | 169738 | 2023-03-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 3.8619 | 1901126 | 91339 | 2023-03-31 | LOW |
Champlain Investment Partners, LLC | Investment Advisor | 3.7109 | 1826825 | -33580 | 2023-03-31 | LOW |
Braidwell LP | Hedge Fund | 3.5637 | 1754350 | 49798 | 2023-03-31 | HIGH |
Mubadala Investment Company PJSC | Sovereign Wealth Fund | 2.9346 | 1444665 | -1445678 | 2021-12-07 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.6458 | 1302457 | 129782 | 2023-03-31 | LOW |
Eagle Health Investments LP | Hedge Fund | 2.4384 | 1200385 | -20224 | 2023-03-31 | MED |
Perceptive Advisors LLC | Private Equity | 2.213 | 1089427 | 0 | 2023-03-31 | MED |
C WorldWide Asset Management Fondsmaeglerselskab A/S | Investment Advisor | 2.0314 | 1000000 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8701 | 920601 | 35123 | 2023-03-31 | LOW |
Pura Vida Investments, LLC | Hedge Fund | 1.8671 | 919136 | 464746 | 2023-03-31 | HIGH |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 1.6427 | 808658 | -100994 | 2023-03-31 | LOW |
Columbia Wanger Asset Management, LLC | Investment Advisor | 1.4124 | 695303 | 157420 | 2023-03-31 | MED |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2327 | 606819 | -3405 | 2023-03-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.1932 | 587411 | -16224 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Outset Medical, Inc. Company profile
关于 Outset Medical Inc.
Outset Medical, Inc.是一家医疗技术公司,提供Tablo。 Tablo是一种用于急性和家庭血液透析治疗的移动综合血液透析解决方案。 水净化和按需生产透析液的整合使Tablo成为车轮上的透析诊所,并使提供者能够从医院到家庭使用一个平台。 Tablo滤芯是一种一次性消耗品,旨在为病人提供体外血液净化服务,由预先配置的血液、盐水和输液管组成。 Tablo的触摸屏面板使用户能够通过动画和非技术语言浏览治疗过程,为专业和非专业用户量身定做。 Tablo的云连接软件实现了机器诊断和分析、治疗指导、监测和报告、改进文档和远程机器管理的生态系统。 此外,Tablo还能提供强大的临床护理。
Industry: | Advanced Medical Equipment & Technology (NEC) |
3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。